Cardiovascular Complications of HIV Infection
Keywords:
MedicineReferences
1. Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquired immune deficiency syndrome. Am Heart J. 1991; 122:535-544.
2. Sadigh M, Puttagunta S. Cardiac manifestations of HIV. Front Biosci. 2003 May 1; 8:s305-13.
3. Mallon PW, Cooper DA, Carr A. HIV-associated lipodystrophy. HIV Med. 2001; 2(3):166-73.
4. Rerkpattanapipat, Pairoj MD, Wongpraparut, Nattawut MD, et al. Cardiac Manifestations of Acquired Immunodeficiency Syndrome. Arch Internal Med. 2000; 160(5):602-608.
5. Heidenreich PA, Eisenberg MJ, Kee LL. Pericardial effusion in AIDS: incidence and survival. Circulation 1995; 92: 3229–3234.
6. Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr Opin Cardiol. 1996 May; 11(3):325-31. 7. Anderson DW, Virmani R, Reilly JM. Prevalent myocarditis at necropsy in acquired immunodeficiency syndrome. J Am Coll Cardiol. 1988; 11:792-799.
8. Himelman RB, Chung WS, Chernoff DN, Schiller NB, et al. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989; 13:1030-1036.
9. Roldan EO, Moskowitz L, Hensley GT. Pathology of the heart in acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1987; 111:943-946.
10. Nathan PE, Arsura EL, Zappi M. Pericarditis with tamponade due to cytomegalovirus in the acquired immunodeficiency syndrome. Chest 1991; 99:765-766.
11. Barbaro, Giuseppe MD. Cardiovascular Manifestations of HIV Infection. Circulation 2002; 106(11):1420-1425.
12. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. NEJM. 1998; 339:1093-1099.
13. Currie PF, Goldman JH, Caforio AL. Cardiac autoimmunity in HIV related heart muscle disease. Heart 1998; 79: 599-604.
14. Carrillo-Jimenez R, Lamas GA, Henneken CH. Plasma levels of brain natriuretic peptide: a potential marker for HIV_related cardiomyopathy. J Cardiovasc Pharmacol Ther. 2002 Jul; 7(3):135-7.
15. Kavanaugh-McHugh AL, Ruff AL, Perlman E, Hutlon N, et al. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. JPEN. 1991; 15:347-349.
16. Hoffman M, Lipshultz SE, Miller TL. Malnutrition and cardiac abnormalities in the HIV-infected patients.In: Miller TL, Gorbach S, eds. Nutritional Aspects of HIV Infection. London, UK: Arnold; 1999; 33-39.
17. Lewis W, Grupp IL, Grupp G. Cardiac dysfunction in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest. 2000; 80: 187-197.
18. Lipshultz SE, Orav EJ, Sanders SP. Immunoglobulins and left ventricular structure and function in pediatrics HIV infection. Circulation 1995; 92: 2220-2225.
19. Currie PF, Sutherland GR, Jacob AJ, Bell JE, et al. A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection. Eur Heart J. 1995; 16 (suppl B):15-18.
20. Barbaro G, Di Lorenzo G, Grisorio B. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 1998: 14: 1071-1077.
21. Patel RC, Frishman WH. Cardiac involvement in HIV infection. Med Clin North Am. 1996; 80:1493- 1512.
22. Nahass RG, Weinstein MP, Bartels J. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and - positive patients. J Infect Dis. 1990; 162: 967-970.
23. Hui DY. HIV protease inhibitors and atherosclerosis. J Clin Invest. 2003; 111:317-318.
24. Dresmman J. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest. 2003; 111:389-397.
25. Carrillo-Jimenez R, Lamas GA, Henneken CH. Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients. J Cardiovasc Pharmacol Ther. 2002 Oct; 7(4):207-10.
26. Van der Valk M, Reiss P. Lipid profiles associated with antiretroviral drug choices. Curr Opin Infect Dis. 2003 Feb; 16(1):19-23.
27. Mehta NJ, Khan IA. HIV-Associated Coronary Artery Disease. Angiology 2003 May/Jun; 54(3):269- 275.
28. Vittecoq D, Escaut L, Chironi G. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era. AIDS 2003 Apr; 17 Suppl 1:S70-6.
29. Matetzky S, Domingo M, Kar S. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003 24; 163(4):457-60. 30. Sattler FR, Qian D, Louie S. Elevated blood pressure in subjects with lipodystrophy. AIDS 2001; 15: 2001-2010.
31. Aoun S, Ramos E. Hypertension in the HIV- infected patient. Curr Hypertens Rep. 2000; 2: 478- 481.
32. Witz M, Lehmann J, Korzets Z. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection. Am J Hematol. 2000; 64: 137-139.
33. Hadigan C, Meigs JB, Rabe J. Increased PAI-1 and t-PA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab. 2001; 86: 939-943.
34. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension. Mayo Clin Proc. 1998; 73:37- 44.
35. Pellicelli AM, Palmieri F, D'Ambrosio C. Role of human immunodeficiency virus in primary pulmonary hypertension: case reports. Angiology 1998; 49: 1005- 1011.
36. Mette SA, Palevsky HI, Pietra GG. Primary pulmonary hypertension in association with human
immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis. 1992; 145:1196-1200. 37. Coplan NL, Shimony RY, Loachim HL. Primary pulmonary hypertension associated with human immunodeficiency viral infection. Am J Med. 1990; 89:96-99.
38. Aguilar RV, Farber HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care 2000; 162: 1846- 1850.
39. Roberts WC. Primary and secondary neoplasms of the heart. Am J Cardiol. 1997; 80:671-682.
40. Holladay AO, Siegel RJ, Schwartz DA. Cardiac malignant lymphoma in acquired immune deficiency syndrome. Cancer 1992; 70:2203-2207.
41. Goldfarb A, King CL, Rosenzweig BP. Cardiac lymphoma in the acquired immunodeficiency syndrome. Am Heart J. 1989; 118:1340-1344.
42. Aboulafia DM, Bush R, Picozzi VJ. Cardiac tamponade due to primary pericardial lymphoma in a patient with AIDS. Chest 1994; 106:1295-1299.
43. Duong M, Dubois C, Buisson M. Non-Hodgkin's lymphoma of the heart in patients infected with human immunodeficiency virus. Clin Cardiol. 1997; 20:497- 502.
44. Arsura EL, Ismail Y, Freeman S, Karunakav AR. Amphotericin B-induced dilated cardiomyopathy. Am J Med. 1994; 97:560-562.
45. Le Y, Rana KZ, Dudley MN. Amphotericin B- associated hypertension. Ann Pharmacother. 1996; 30:765-767.
46. Brown DL, Sather S, Cheitlin MD. Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J. 1993; 125:1439-1441.
47. Raine AE. Hypertension, blood viscosity and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1988; 1:97-100
48. Sonnenblick M, Rosin A. Cardiotoxicity of interferon: a review of 44 cases. Chest 1991; 99:557- 561.
49. Cohen AJ, Weiser B, Afzal Q, Fuhrer J. Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG). AIDS 1990; 4:807-809.
50. Girgis I, Gualberti J, Langan L. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. Chest 1997; 112:646-653.
51. Von Seidlein L, Jaffar S, Greenwood B. Prolongation of QTc interval in African children treated for falciparum malaria. Am J Trop Med Hyg. 1997; 56:494-497.
52. Lopez JA, Harold JG, Rosenthal MC, Oseran DS, et al. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol. 1987; 59:376-377.
53. Hervas I, Osca J, Perez-Pastor J. Radioimmunometric assay of natriuretic peptide type-B (BNP) in heart failure. Nucl Med Communications 2003; 24(1):61-69.
54. Harmon WG, Dadlani GH, Fisher SD. Myocardial and Pericardial Disease in HIV. Curr Treat Options Cardiovasc Med. 2002 Dec; 4(6):497-509.
2. Sadigh M, Puttagunta S. Cardiac manifestations of HIV. Front Biosci. 2003 May 1; 8:s305-13.
3. Mallon PW, Cooper DA, Carr A. HIV-associated lipodystrophy. HIV Med. 2001; 2(3):166-73.
4. Rerkpattanapipat, Pairoj MD, Wongpraparut, Nattawut MD, et al. Cardiac Manifestations of Acquired Immunodeficiency Syndrome. Arch Internal Med. 2000; 160(5):602-608.
5. Heidenreich PA, Eisenberg MJ, Kee LL. Pericardial effusion in AIDS: incidence and survival. Circulation 1995; 92: 3229–3234.
6. Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr Opin Cardiol. 1996 May; 11(3):325-31. 7. Anderson DW, Virmani R, Reilly JM. Prevalent myocarditis at necropsy in acquired immunodeficiency syndrome. J Am Coll Cardiol. 1988; 11:792-799.
8. Himelman RB, Chung WS, Chernoff DN, Schiller NB, et al. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989; 13:1030-1036.
9. Roldan EO, Moskowitz L, Hensley GT. Pathology of the heart in acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1987; 111:943-946.
10. Nathan PE, Arsura EL, Zappi M. Pericarditis with tamponade due to cytomegalovirus in the acquired immunodeficiency syndrome. Chest 1991; 99:765-766.
11. Barbaro, Giuseppe MD. Cardiovascular Manifestations of HIV Infection. Circulation 2002; 106(11):1420-1425.
12. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. NEJM. 1998; 339:1093-1099.
13. Currie PF, Goldman JH, Caforio AL. Cardiac autoimmunity in HIV related heart muscle disease. Heart 1998; 79: 599-604.
14. Carrillo-Jimenez R, Lamas GA, Henneken CH. Plasma levels of brain natriuretic peptide: a potential marker for HIV_related cardiomyopathy. J Cardiovasc Pharmacol Ther. 2002 Jul; 7(3):135-7.
15. Kavanaugh-McHugh AL, Ruff AL, Perlman E, Hutlon N, et al. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. JPEN. 1991; 15:347-349.
16. Hoffman M, Lipshultz SE, Miller TL. Malnutrition and cardiac abnormalities in the HIV-infected patients.In: Miller TL, Gorbach S, eds. Nutritional Aspects of HIV Infection. London, UK: Arnold; 1999; 33-39.
17. Lewis W, Grupp IL, Grupp G. Cardiac dysfunction in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest. 2000; 80: 187-197.
18. Lipshultz SE, Orav EJ, Sanders SP. Immunoglobulins and left ventricular structure and function in pediatrics HIV infection. Circulation 1995; 92: 2220-2225.
19. Currie PF, Sutherland GR, Jacob AJ, Bell JE, et al. A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection. Eur Heart J. 1995; 16 (suppl B):15-18.
20. Barbaro G, Di Lorenzo G, Grisorio B. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 1998: 14: 1071-1077.
21. Patel RC, Frishman WH. Cardiac involvement in HIV infection. Med Clin North Am. 1996; 80:1493- 1512.
22. Nahass RG, Weinstein MP, Bartels J. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and - positive patients. J Infect Dis. 1990; 162: 967-970.
23. Hui DY. HIV protease inhibitors and atherosclerosis. J Clin Invest. 2003; 111:317-318.
24. Dresmman J. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest. 2003; 111:389-397.
25. Carrillo-Jimenez R, Lamas GA, Henneken CH. Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients. J Cardiovasc Pharmacol Ther. 2002 Oct; 7(4):207-10.
26. Van der Valk M, Reiss P. Lipid profiles associated with antiretroviral drug choices. Curr Opin Infect Dis. 2003 Feb; 16(1):19-23.
27. Mehta NJ, Khan IA. HIV-Associated Coronary Artery Disease. Angiology 2003 May/Jun; 54(3):269- 275.
28. Vittecoq D, Escaut L, Chironi G. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era. AIDS 2003 Apr; 17 Suppl 1:S70-6.
29. Matetzky S, Domingo M, Kar S. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003 24; 163(4):457-60. 30. Sattler FR, Qian D, Louie S. Elevated blood pressure in subjects with lipodystrophy. AIDS 2001; 15: 2001-2010.
31. Aoun S, Ramos E. Hypertension in the HIV- infected patient. Curr Hypertens Rep. 2000; 2: 478- 481.
32. Witz M, Lehmann J, Korzets Z. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection. Am J Hematol. 2000; 64: 137-139.
33. Hadigan C, Meigs JB, Rabe J. Increased PAI-1 and t-PA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab. 2001; 86: 939-943.
34. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension. Mayo Clin Proc. 1998; 73:37- 44.
35. Pellicelli AM, Palmieri F, D'Ambrosio C. Role of human immunodeficiency virus in primary pulmonary hypertension: case reports. Angiology 1998; 49: 1005- 1011.
36. Mette SA, Palevsky HI, Pietra GG. Primary pulmonary hypertension in association with human
immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis. 1992; 145:1196-1200. 37. Coplan NL, Shimony RY, Loachim HL. Primary pulmonary hypertension associated with human immunodeficiency viral infection. Am J Med. 1990; 89:96-99.
38. Aguilar RV, Farber HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care 2000; 162: 1846- 1850.
39. Roberts WC. Primary and secondary neoplasms of the heart. Am J Cardiol. 1997; 80:671-682.
40. Holladay AO, Siegel RJ, Schwartz DA. Cardiac malignant lymphoma in acquired immune deficiency syndrome. Cancer 1992; 70:2203-2207.
41. Goldfarb A, King CL, Rosenzweig BP. Cardiac lymphoma in the acquired immunodeficiency syndrome. Am Heart J. 1989; 118:1340-1344.
42. Aboulafia DM, Bush R, Picozzi VJ. Cardiac tamponade due to primary pericardial lymphoma in a patient with AIDS. Chest 1994; 106:1295-1299.
43. Duong M, Dubois C, Buisson M. Non-Hodgkin's lymphoma of the heart in patients infected with human immunodeficiency virus. Clin Cardiol. 1997; 20:497- 502.
44. Arsura EL, Ismail Y, Freeman S, Karunakav AR. Amphotericin B-induced dilated cardiomyopathy. Am J Med. 1994; 97:560-562.
45. Le Y, Rana KZ, Dudley MN. Amphotericin B- associated hypertension. Ann Pharmacother. 1996; 30:765-767.
46. Brown DL, Sather S, Cheitlin MD. Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J. 1993; 125:1439-1441.
47. Raine AE. Hypertension, blood viscosity and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1988; 1:97-100
48. Sonnenblick M, Rosin A. Cardiotoxicity of interferon: a review of 44 cases. Chest 1991; 99:557- 561.
49. Cohen AJ, Weiser B, Afzal Q, Fuhrer J. Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG). AIDS 1990; 4:807-809.
50. Girgis I, Gualberti J, Langan L. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. Chest 1997; 112:646-653.
51. Von Seidlein L, Jaffar S, Greenwood B. Prolongation of QTc interval in African children treated for falciparum malaria. Am J Trop Med Hyg. 1997; 56:494-497.
52. Lopez JA, Harold JG, Rosenthal MC, Oseran DS, et al. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol. 1987; 59:376-377.
53. Hervas I, Osca J, Perez-Pastor J. Radioimmunometric assay of natriuretic peptide type-B (BNP) in heart failure. Nucl Med Communications 2003; 24(1):61-69.
54. Harmon WG, Dadlani GH, Fisher SD. Myocardial and Pericardial Disease in HIV. Curr Treat Options Cardiovasc Med. 2002 Dec; 4(6):497-509.
Downloads
Published
2004-01-01
How to Cite
Chong, G. (2004). Cardiovascular Complications of HIV Infection. Trinity Student Medical Journal , 5(1), Page 31–36. Retrieved from https://ojs.tchpc.tcd.ie/index.php/tsmj/article/view/1936
Issue
Section
Reviews
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
